Biobanques tumorales et gestion des données complexes : enjeux actuels et futurs

Annales de Pathologie - Tập 39 - Trang 137-143 - 2019
Paul Hofman1,2,3, Georges Dagher4, Pierre Laurent-Puig5, Charles-Hugo Marquette3,6, Fabrice Barlesi7, Frédéric Bibeau8, Bruno Clément9
1Laboratoire de pathologie clinique et expérimentale, hôpital Pasteur, université Côte d’Azur, CHU de Nice, BP 69, 30, avenue de la Voie-Romaine, 06001 Nice cedex 01, France
2Biobanque hospitalière (BB-0033-00025), hôpital Pasteur, université Côte d’Azur, CHU de Nice, BP 69, 30, avenue de la Voie-Romaine, 06001 Nice cedex 01, France
3FHU OncoAge, hôpital Pasteur, université Côte d’Azur, CHU de Nice, BP 69, 30, avenue de la Voie-Romaine, 06001 Nice cedex 01, France
4Biobanques, Inserm US013, hôpital de la Salpêtrière, 47, boulevard de l’Hôpital, 75651 Paris, France
5UMR-1138, Inserm, département de biologie, hôpital européen Georges-Pompidou, université Paris Descartes, Assistance publique–Hôpitaux de Paris, 20, rue Leblanc, 75015 Paris, France
6Service de pneumologie, hôpital Pasteur, université Côte d’Azur, CHU de Nice, BP 69, 30, avenue de la Voie-Romaine, 06001 Nice cedex 01, France
7Service d’oncologie multidisciplinaire et innovations thérapeutiques, Aix-Marseille université, Assistance publique–Hôpitaux de Marseille, 13920 Marseille cedex 15, France
8Laboratoire de pathologie, CHU de Caen, avenue de la Côte-de-Nacre, 14000 Caen, France
9Inserm, Inra, nutrition métabolismes et cancer, CRB-Santé, université de Rennes, rue Henri-Le-Guilloux, 35033 Rennes, France

Tài liệu tham khảo

Hewitt, 2011, Biobanking: the foundation of personalized medicine, Curr Opin Oncol, 23, 112, 10.1097/CCO.0b013e32834161b8 Liu, 2015, Biobanking for personalized medicine, Adv Exp Med Biol, 864, 55, 10.1007/978-3-319-20579-3_5 Vaught, 2016, Biobanking comes of age: the transition to biospecimen science, Annu Rev Pharmacol Toxicol, 56, 211, 10.1146/annurev-pharmtox-010715-103246 Zatloukal, 2010, Human tissue biobanks as instruments for drug discovery and development: impact on personalized medicine, Biomark Med, 4, 895, 10.2217/bmm.10.104 Bycroft, 2018, The UK Biobank resource with deep phenotyping and genomic data, Nature, 562, 203, 10.1038/s41586-018-0579-z Doucet, 2017, Quality matters: 2016 Annual Conference of the National Infrastructures for Biobanking, Biopreserv Biobank, 15, 270, 10.1089/bio.2016.0053 Simeon-Dubach, 2014, Biobanking 3.0: evidence based and customer focused biobanking, Clin Biochem, 47, 300, 10.1016/j.clinbiochem.2013.12.018 Chabannon, 2010, Publication of biological samples collections catalogues by tumor banks, Bull Cancer, 97, 181, 10.1684/bdc.2009.0963 Gaffney, 2018, Factors that drive the increasing use of FFPE tissue in basic and translational cancer research, Biotech Histochem, 93, 373, 10.1080/10520295.2018.1446101 Clément, 2014, EU-US Expert Group on cost recovery in biobanks. Public biobanks: calculation and recovery of costs, Sci Transl Med, 6, 261fs45, 10.1126/scitranslmed.3010444 Furuta, 2018, Standardization and innovation in paving a path to a better future: an update of activities in ISO/TC276/WG2 biobanks and bioresources, Biopreserv Biobank, 16, 23, 10.1089/bio.2017.0117 Hofman, 2013, Measuring the contribution of tumor biobanks to research in oncology: surrogate indicators and bibliographic output, Biopreserv Biobank, 11, 235, 10.1089/bio.2013.0015 McCall, 2018, The College of American Pathologists Biorepository Accreditation Program: results from the first 5 years, Biopreserv Biobank, 16, 16, 10.1089/bio.2017.0108 Hofman, 2014, Public–private relationships in biobanking: a still underestimated key component of open innovation, Virchows Arch, 464, 3, 10.1007/s00428-013-1524-z Hofman, 2018, The policies of tumor biobankers: main strategies and an example of the polices adopted by the Nice Hospital biobank, France Patil, 2018, Cancer oriented biobanks: a comprehensive review, Oncol Rev, 12, 357 Rush, 2018, Research perspective on utilizing and valuing tumor biobanks, Biopreserv Biobank Washetine, 2018, Establishing a dedicated lung cancer biobank at the University Center Hospital of Nice (France). Why and how?, Cancers (Basel), 10, 10.3390/cancers10070220 Hofman, 2010, The Nice CHU biobank experience to collect patients’ informed consent for research context (2004–2009), Ann Pathol, 30, 337, 10.1016/j.annpat.2010.09.002 Heeke, 2018, Use of the ion PGM and the GeneReader NGS systems in daily routine practice for advanced lung adenocarcinoma patients: a practical point of view reporting a comparative study and assessment of 90 patients, Cancers (Basel), 10, 10.3390/cancers10040088 Ilie, 2015, Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps, Cancer Med, 4, 201, 10.1002/cam4.357 Yada, 2017, Use of patient-derived xenograft mouse models in cancer research and treatment, Future Sci OA, 4, FSO271, 10.4155/fsoa-2017-0136 Zisis, 2016, Biobanking with big data: a need for developing “big data metrics”, Biopreserv Biobank, 14, 450, 10.1089/bio.2015.0106 Cox, 2018, UK Biobank shares the promise of big data, Nature, 562, 194, 10.1038/d41586-018-06948-3 de Lecuona, 2018, European perspectives on big data applied to health: the case of biobanks and human databases, Dev World Bioeth, 18, 291, 10.1111/dewb.12208 Clermont, 2014, Assessment of DNA encapsulation, a new room temperature DNA storage method, Biopreserv Biobank, 12, 176, 10.1089/bio.2013.0082 Washetine, 2018, Ensuring the safety and security of frozen lung cancer tissue collections through the encapsulation of dried DNA, Cancers (Basel), 10, 10.3390/cancers10060195 Washetine, 2019, DNAshell protects DNA stored at room temperature for downstream NGS studies, Biopreserv Biobank, 10.1089/bio.2018.0129 Chakraborty, 2018, Onco-Multi-OMICS approach: a new frontier in cancer research, Biomed Res Int, 2018, 9836256, 10.1155/2018/9836256 Sun, 2018, A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study, Lancet Oncol, 19, 1180, 10.1016/S1470-2045(18)30413-3 Wang, 2018, Detecting personalized determinates during drug treatment from omics big data, Curr Pharm Des, 24, 3727, 10.2174/1381612824666181106102111 Hamilton, 2014, Digital pathology and image analysis in tissue biomarker research, Methods, 70, 59, 10.1016/j.ymeth.2014.06.015 Harati, 2019, An introduction to starting a biobank, Methods Mol Biol, 1897, 7, 10.1007/978-1-4939-8935-5_2 Mabile, 2013, Quantifying the use of bioresources for promoting their sharing in scientific research, Gigascience, 2, 7, 10.1186/2047-217X-2-7 He, 2019, The practical implementation of artificial intelligence technologies in medicine, Nat Med, 25, 30, 10.1038/s41591-018-0307-0 Koelzer, 2018, Precision immunoprofiling by image analysis and artificial intelligence, Virchows Arch Salto-Tellez, 2018, Artificial intelligence – The third revolution in pathology, Histopathology, 74, 372, 10.1111/his.13760 Sherbet, 2018, Application of artificial intelligence-based technology in cancer management: a commentary on the deployment of artificial neural networks, Anticancer Res, 38, 6607, 10.21873/anticanres.13027 Topol, 2019, High-performance medicine: the convergence of human and artificial intelligence, Nat Med, 25, 44, 10.1038/s41591-018-0300-7 Price, 2019, Privacy in the age of medical big data, Nat Med, 25, 37, 10.1038/s41591-018-0272-7 Gormally, 2017, Training the next generation of biobankers: a two-year master's course in the management of biobanks, Biopreserv Biobank, 15, 438, 10.1089/bio.2017.0002 Williams, 2019, Orientation and training of new biobank personnel, Methods Mol Biol, 1897, 51, 10.1007/978-1-4939-8935-5_6 Lee, 2017, Impact of preanalytical variations in blood-derived biospecimens on omics studies: toward precision biobanking?, OMICS, 21, 499, 10.1089/omi.2017.0109 Dagher, 2018, Le « next generation biobanking », un défi des données numériques, Med Sci (Paris), 34, 849, 10.1051/medsci/2018203